Literature DB >> 12147560

Medical therapy for the overactive bladder in the elderly.

Adrian Wagg1, Maurice Cohen.   

Abstract

The overactive bladder is the commonest underlying bladder disorder causing urinary incontinence in elderly people. Management of the condition relies upon a holistic assessment of the problem, lifestyle adjustment, behavioural management and drug therapy. The majority of currently available drugs rely on their anti-muscarinic properties for efficacy. Both behavioural techniques and drug therapy are effective in treatment of the elderly and each modality has a particular role to play in successful treatment and maintenance of this condition.

Entities:  

Mesh:

Year:  2002        PMID: 12147560     DOI: 10.1093/ageing/31.4.241

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  6 in total

Review 1.  Translational Research and Functional Changes in Voiding Function in Older Adults.

Authors:  Florenta Aura Kullmann; Lori Ann Birder; Karl-Erik Andersson
Journal:  Clin Geriatr Med       Date:  2015-07-23       Impact factor: 3.076

Review 2.  Overactive bladder in the elderly: a guide to pharmacological management.

Authors:  David R Staskin
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 3.  Perspectives on overactive bladder in the elderly population.

Authors:  Masaki Yoshida
Journal:  World J Urol       Date:  2009-11-11       Impact factor: 4.226

4.  Trospium and cognition in patients with late onset Alzheimer disease.

Authors:  A T Isik; T Celik; E Bozoglu; H Doruk
Journal:  J Nutr Health Aging       Date:  2009-10       Impact factor: 4.075

5.  Changes in nerve-mediated contractility of the lower urinary tract in a mouse model of premature ageing.

Authors:  D Triguero; A Lafuente-Sanchis; A Garcia-Pascual
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 6.  The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly.

Authors:  Danny Ulahannan; Adrian Wagg
Journal:  Clin Interv Aging       Date:  2009-05-14       Impact factor: 4.458

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.